What is the frequency of cardiovascular risk factors and co-morbidity in patients with rheumatic diseases?

被引:0
|
作者
Bertin, Philippe [1 ]
机构
[1] CHU Dupuytren, Serv Therapeut & Rhumatol, F-87000 Limoges, France
来源
PRESSE MEDICALE | 2006年 / 35卷 / 09期
关键词
D O I
10.1016/S0755-4982(06)74935-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Analysis of national data from the health ministry programme of reduction of the cardiovascular risks (2002-2005) shows a high frequency of cardiovasculor disease and cardiovascular risk factors in the general population. It is of interest to analyse these data in relation to the practice of rheumotology In addition, the frequency of cardiovascular pathologies is higher in patients with rheumatoid arthritis and spondylorthropathy These notions ore also very important since these two populations are often treated with non-steroid(71 anti-inflammatory drugs for a long duration. General knowledge shown in this article concerning the Cardiovascular risk factors and co-morbidities in the patients with rheumatic pathologies allows, within the context of a therapeutic decisionol strategy in rheumotology a better estimation of the individual benefit/risk ratio of each prescription and more particularly that of non-steroidal antiinflammatory drugs.
引用
收藏
页码:5 / 9
页数:5
相关论文
共 50 条
  • [1] Cardiovascular co-morbidity in patients with rheumatic diseases
    Johan Frostegård
    [J]. Arthritis Research & Therapy, 13
  • [2] Cardiovascular co-morbidity in patients with rheumatic diseases
    Frostegard, Johan
    [J]. ARTHRITIS RESEARCH & THERAPY, 2011, 13 (03)
  • [3] Cardiovascular co-morbidity in rheumatic diseases
    Turesson, Carl
    Jacobsson, Lennart T. H.
    Matteson, Eric L.
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (03) : 605 - 614
  • [4] Renal co-morbidity in patients with rheumatic diseases
    Hans-Joachim Anders
    Volker Vielhauer
    [J]. Arthritis Research & Therapy, 13
  • [5] Renal co-morbidity in patients with rheumatic diseases
    Anders, Hans-Joachim
    Vielhauer, Volker
    [J]. ARTHRITIS RESEARCH & THERAPY, 2011, 13 (03)
  • [6] CO-MORBIDITY IN RHEUMATIC DISEASES
    Klareskog, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 31 - 31
  • [7] Cardiovascular co-morbidity in patients with rheumatoid arthritis: A narrative review of risk factors, cardiovascular risk assessment and treatment
    Jagpal A.
    Navarro-Millán I.
    [J]. BMC Rheumatology, 2 (1)
  • [8] Cardiovascular risk factors in patients with rheumatic diseases
    Hernandez Batista, Sulema de la Caridad
    Villafuerte Morales, Johanna Elizabeth
    Chimbolema Mullo, Sergio Orlando
    Pilamunga Lema, Cesar Lenin
    [J]. REVISTA CUBANA DE REUMATOLOGIA, 2020, 22 (01):
  • [9] Non-cardiovascular co-morbidity in elderly patients with heart failure outnumbers cardiovascular co-morbidity
    van der Wel, Mark C.
    Jansen, Rene W. M. M.
    Bakx, J. Carel
    Bor, Hans H. J.
    OldeRikkert, Marcel G. M.
    van Weel, Chris
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (6-7) : 709 - 715
  • [10] Cardiovascular Co-Morbidity
    不详
    [J]. UNFALLCHIRURG, 2011, 114 (08): : 653 - 653